Halozyme
HALO
325 hedge funds and large institutions have $5.2B invested in Halozyme in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 125 increasing their positions, 115 reducing their positions, and 41 closing their positions.
98% more call options, than puts
Call options by funds: $22.7M | Put options by funds: $11.4M
9% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 115
0.68% more ownership
Funds ownership: 91.23% → 91.91% (+0.68%)
0% more funds holding
Funds holding: 324 → 325 (+1)
15% less capital inflows, than outflows
Capital inflows: $229M | Capital outflows: $269M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
29% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Snyder Capital Management
San Francisco,
California
|
+$23.8M |
| 2 |
Goldman Sachs
New York
|
+$18.6M |
| 3 |
EcoR1 Capital
San Francisco,
California
|
+$14.6M |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$12.4M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$24.2M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$21.3M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$18.3M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$16.9M |
| 5 |
HealthCor Management
New York
|
-$14.5M |
HALO Hedge Fund Activity: Q4 2021 in Review
325 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2021, worth a combined $5.2B — down 1.5% from $5.28B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of HALO and 29 opened new positions — a net loss of 12 holders — while 115 trimmed existing stakes and 125 added.
The largest buyer was Snyder Capital Management, adding an estimated $23.8M. The largest seller was Fiera Capital (Canada), exiting entirely with an estimated $24.2M sold.
- 325 institutional investors held Halozyme (HALO) as of Q4 2021, up from 324 in Q3 2021.
- Funds reported $5.2B of Halozyme stock for Q4 2021, down 1.5% quarter-over-quarter.
- 29 funds opened new Halozyme positions in Q4 2021 and 41 closed out, a net change of -12 holders.
- The largest Halozyme buyer in Q4 2021 was Snyder Capital Management, an estimated $23.8M added.
- The largest Halozyme seller in Q4 2021 was Fiera Capital (Canada), an estimated $24.2M sold.
Based on aggregated 13F filings for Q4 2021.